The government’s “My Health 2022” strategy places the improvement of the organization of care, particularly in chronic diseases, as well as the digitalization of the health system at the top of its priorities. Alcimed explored the relevance of digital solutions for the organization of care as well as the perspectives offered to healthcare stakeholders.

Preclinical testing is perceived as an unavoidable and problematic step in drug development, with the major disadvantage of provoking ethical controversies related to animal welfare, while not always guaranteeing relevant results for manufacturers. Although it has long seemed unavoidable, the new organ modeling technology, “Organ-on-a-chip”, now seems to be on the way to bringing about innovation to this key stage.

After several years of listening to all stakeholders in the Unmanned Aerial Vehicle (UAV) market, and a dialogue with European and American national civil aviation agencies, the European Union Aviation Safety Agency (EASA) has finally published European regulations to provide a harmonized framework for UAV operators and manufacturers in Europe.

Ultra-resistant or super-adhesive materials, survival at great depths or adaptation to amphibious life, with 3.6 billion years of R&D, the world of nature has proven that its ability to develop cutting-edge technologies. These feats, which are by their very essence respectful of their environment, have always been a source of inspiration for manufacturers. That innovative […]

At the end of 2018, the French Ministry of Solidarity and Health announced the 10 priorities of the “My health 2022” plan (in French, “Ma santé 2022”). In March 2019, Minister Agnès Buzyn declared that “among the many initiatives, digital health faces immense challenges”, starting with the transformation of training models for healthcare professionals. In […]

Predicting what the world of healthcare will look like in 2050 is a major challenge, yet the key trends in innovation combined with certain weaker signals suggest that the patient’s condition is likely to change over the next 30 years. In order to decipher the opportunities and challenges that will come along with the transformation […]

In the debate between traditional and alternative medicine, the French Minister for Solidarity and Health, Agnès Buzyn has asked the HAS, the French Health Agency (Haute autorité de santé), to reassess the reimbursement of homeopathic medicines. Not surprisingly, on June 28, the French Health Agency issued a negative opinion on the reimbursement of homeopathic medicines […]

More than 20 years ago, the “green wave” swept through the industry. We were then talking about “green washing”, referring to a set of more or less coordinated, opportunistic actions that were used to make the offers in place “greener”. But some companies have used this underlying thought to reinvent themselves. They have been able […]

Photobiomodulation could reduce some of the side effects of cancer treatments such as mucositis and dermatitis. Doctors have high hopes for this new therapy, although they are waiting for a proof of efficacy and tolerance. Moreover, photobiomodulation has a large potential, as this procedure is not limited to oncology. Photobiomodulation, a new therapy to treat […]

Alcimed, an innovation & new business consulting firm, has explored the trends in the liquid biopsy field and discusses some of the challenges as players move from the Non-invasive Prenatal Testing (NIPT) market toward further validation in oncology. Liquid biopsy’s first application was in non-invasive prenatal testing with an explosive market penetration. Liquid biopsy has […]